Grants and Contributions

Construction and Infrastructure Upgrades: The project will construct mountain bike trails in Montebello, Notre-Dame-de Bonsecours and Papineauville to support the development of this community to recover from the effects of the COVID-19 pandemic.

Community Facility: The project aims to improve the outdoor sports facilities and the community center of the municipality of St-Armand in order to promote the development of this community so that it can recover from the effects of the COVID-19 pandemic.

Community Facility: the project aims to improve the outdoor sports facilities and the community center of the municipality in order to promote the development of this community so that it can recover from the effects of the COVID-19 pandemic.

To address the challenges of SARS2 COVID-19 pandemic, messenger ribonucleic acid (mRNA) vaccines were developed.

These needs are worsened by the ongoing impacts of the coronavirus (COVID-19) pandemic, other health epidemics, increased violence across eastern provinces and political uncertainty.

To construct critical infrastructure to enhance airport safety

The purpose of these funds is to provide the institution responsible for administering the Operating Grant : Canadian Network of COVID-19 Clinical Trials Networks (CNCCTN) Extension, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.

The specific objectives of this funding opportunity are to:

• Support an adaptive platform trial that is aimed at evaluating the effectiveness (including comparative clinical and cost-effectiveness), practical challenges, and outcomes of administering therapeutics for COVID-19 to non-hospitalized patients in Canadian healthcare settings using well-structured studies and well-defined outcome measures (e.g., the Core Outcomes Set (COS) for Trials in People With Coronavirus Disease 2019);
• Generate evidence on treatment effectiveness diverse populations.

The specific objectives of this funding opportunity are to continue to:
• Provide central coordination and lead collaboration activities with clinical trials groups/networks in a transparent and inclusive manner to increase the availability of high-quality and real-time clinical trial evidence to prevent, diagnose, and/or treat COVID-19 (e.g., through clinical trials of vaccines, therapeutics, or diagnostic tests);
• Collaborate across member networks to expand resource and data sharing policies, including creating data sharing agreements and increasing efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
• Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences; and
• Engage stakeholders in research prioritization and oversight, provide evidence to inform clinical/ health system management and public health responses, and/or decision-making and planning within and across jurisdictions in Canada and internationally.

The specific objective(s) of this funding opportunity are to continue to:

• Accelerate the knowledge mobilization of high-quality and real-time evidence and/or solutions that responds to an identified evidence need(s) to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and
• Generate evidence related to one or more diverse population(s), by addressing, for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or the needs of racialized or First Nations, Inuit, Metis and Urban Indigenous populations to equitably improve health outcomes across the lifecycle.

Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.